GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (NSE:INDOUS) » Definitions » Net-Net Working Capital

Indo US Bio-Tech (NSE:INDOUS) Net-Net Working Capital : ₹13.72 (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indo US Bio-Tech Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Indo US Bio-Tech's Net-Net Working Capital for the quarter that ended in Mar. 2025 was ₹13.72.

The industry rank for Indo US Bio-Tech's Net-Net Working Capital or its related term are showing as below:

NSE:INDOUS's Price-to-Net-Net-Working-Capital is ranked worse than
60.49% of 81 companies
in the Agriculture industry
Industry Median: 8.02 vs NSE:INDOUS: 11.34

Indo US Bio-Tech Net-Net Working Capital Historical Data

The historical data trend for Indo US Bio-Tech's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Net-Net Working Capital Chart

Indo US Bio-Tech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.54 5.47 1.12 5.00 13.72

Indo US Bio-Tech Quarterly Data
Oct17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.00 11.30 - 13.72

Competitive Comparison of Indo US Bio-Tech's Net-Net Working Capital

For the Agricultural Inputs subindustry, Indo US Bio-Tech's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo US Bio-Tech's Price-to-Net-Net-Working-Capital Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's Price-to-Net-Net-Working-Capital falls into.


;
;

Indo US Bio-Tech Net-Net Working Capital Calculation

Indo US Bio-Tech's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Mar. 2025 is calculated as

Net-Net Working Capital(A: Mar. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2.478+0.75 * 150.008+0.5 * 706.864-193.242
-0-0)/20.052
=13.72

Indo US Bio-Tech's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2025 is calculated as

Net-Net Working Capital(Q: Mar. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2.478+0.75 * 150.008+0.5 * 706.864-193.242
-0-0)/20.052
=13.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Indo US Bio-Tech  (NSE:INDOUS) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Indo US Bio-Tech Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo US Bio-Tech Business Description

Traded in Other Exchanges
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines